SCHEMBL22985341

SCHEMBL22985341

Cc1ccccc1-c1ccc2c(c1)c1cc(-c3ccccc3C)ccc1n2-c1ccc(C#N)cc1-c1ccc(-c2ccc(C(F)(F)F)cc2C#N)cc1-n1c2ccc(-c3ccccc3C)cc2c2cc(-c3ccccc3C)ccc21

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.44
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.35
XDH P47989 2/20 0.34
GPBAR1 Q8TDU6 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
PGGT1B P53609 1/20 0.33
KIF11 P52732 1/20 0.33
ELANE P08246 2/20 0.33
BCAT1 P54687 1/20 0.33
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PGR P06401 2/20 0.32
ERBB2 P04626 1/20 0.31
PTPN5 P54829 1/20 0.31
PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985242 0.97 AR (0.42) ARALOX5APFEN1PTGDR2XDH
SCHEMBL22985711 0.96 AR (0.44) ARALOX5APFEN1PTGDR2XDH
SCHEMBL22985661 0.96 AR (0.46) ARALOX5APFEN1PTGDR2XDH
SCHEMBL22985570 0.96 AR (0.46) ARALOX5APFEN1PTGDR2XDH
SCHEMBL22985710 0.94 AR (0.42) ARALOX5APFEN1PTGDR2XDH
SCHEMBL22985572 0.94 AR (0.43) ARALOX5APFEN1PTGDR2XDH
SCHEMBL22985660 0.94 AR (0.43) ARALOX5APFEN1PTGDR2XDH
SCHEMBL21399457 0.93 AR (0.43) ARPTGDR2GPBAR1KIF11ELANE
SCHEMBL22985134 0.93 ALOX5AP (0.40) ARALOX5APFEN1XDHKIF11
SCHEMBL21399782 0.92 AR (0.43) ARPTGDR2GPBAR1FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 AR 3541/4885ALOX5AP 2567/4885FEN1 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.